Patent Yard Sign in
Canadian application, no grantCanada

Pharmaceutical composition and method for the suppression of factor viii inhibitor production

CA 2002209 A1 · Owner: Masson, Pierre L. · Inventors: Saint-Remy, Jean-Marie; Masson, Pierre L.; Lebrun, Philippe

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

26-, Abstract of the Disclosure, A pharmaceutical composition suitable for administration to human beings for suppressing the production of factor VIII inhibitor includes: an immune complex of factor VIII antigen component and factor VIII inhibitor component, the components being present in a ratio such that the inhibitor blocks essentially all relevant binding sites of the antigen; and, a pharmacologically acceptable carrier or diluent. The invention also provides a method of administering the compositions to suppress the production of inhibitor to factor VIII.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed November 3, 1989. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 3, 2009.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 3, 2011.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledNovember 3, 1989
GrantedNo grant recorded
Term endedNovember 3, 2009
Patent numberCA 2002209 A1
Classification (IPC)A61K39/00 +1 more

Timeline

Timeline From CIPO dates

1990199219941996199820002002200420062008Application filedNov 3, 1989Term endedNov 3, 2009

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.